KIM
63
9
MO
47
5
ADP
65
4
UAL
61
-9
CF
38
12
SBUX
52
3
GM
65
5
URBN
66
4
CME
65
3
OMC
64
-4
ACN
40
2
EBAY
49
2
VZ
20
-9
IPG
61
11
IVZ
40
2
WAT
48
4
BDX
46
9
EXPE
56
-8
VMC
68
2
WM
76
2
KIM
63
9
MO
47
5
ADP
65
4
UAL
61
-9
CF
38
12
SBUX
52
3
GM
65
5
URBN
66
4
CME
65
3
OMC
64
-4
ACN
40
2
EBAY
49
2
VZ
20
-9
IPG
61
11
IVZ
40
2
WAT
48
4
BDX
46
9
EXPE
56
-8
VMC
68
2
WM
76
2
Financhill
Back

Protagonist Therapeutics Vs. Enanta Pharmaceuticals Industry Stock Comparison

Buy
56

PTGX
Protagonist Therapeutics

Last Price:
27.10
Seasonality Move:
25.26%
Sell
38

ENTA
Enanta Pharmaceuticals

Last Price:
13.65
Seasonality Move:
-3.02%
Buy
56
Protagonist Therapeutics (PTGX) is a Buy

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $26.63. The Score for PTGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Enanta Pharmaceuticals (ENTA) is a Sell

Is Enanta Pharmaceuticals a Buy, Sell or Hold?

  • The current Enanta Pharmaceuticals [ENTA] share price is $13.42. The Score for ENTA is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ENTA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $26.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing slight buying pressure.

ENTA Stock Price Chart

What is Enanta Pharmaceuticals's stock price today?

  • The Enanta Pharmaceuticals share price today is $13.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTA is experiencing slight selling pressure.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 44.14 Sell
Chaikin Money Flow: 102476 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.58 - 28.74) Sell
Bollinger Bands (100): (22.17 - 29.21) Buy

ENTA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 36.55 Sell
Chaikin Money Flow: -13152 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.11 - 16.79) Sell
Bollinger Bands (100): (10.32 - 15.16) Buy

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.3 Buy
20-day SMA: 27.44 Sell
50-day SMA: 28.45 Sell
200-day SMA: 21.75 Buy
8-day EMA: 26.38 Buy
20-day EMA: 27.21 Sell
50-day EMA: 27.32 Sell
200-day EMA: 23.42 Buy

ENTA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.83 Sell
20-day SMA: 15.75 Sell
50-day SMA: 14.72 Sell
200-day SMA: 12.98 Buy
8-day EMA: 14.45 Sell
20-day EMA: 15.1 Sell
50-day EMA: 14.57 Sell
200-day EMA: 16.62 Sell

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and a decrease next year of $0.23 per share.

Enanta Pharmaceuticals Earnings Growth & ENTA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.16 per share, an increase this year of $1.86 per share, and an increase next year of $0.05 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Enanta Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):